Skip to content

An observational study of the background, treatment status, and prognosis of patients with severe septic shock

An observational study of the background, treatment status, and prognosis of patients with severe septic shock - Best Available Treatment for septic shock registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000038302
Enrollment
400
Registered
2019-11-01
Start date
2020-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe septic shock

Interventions

None listed

Sponsors

Tohoku University Graduate School of Medicine Division of Emergency and Critical Care Medicine
Lead Sponsor
Hokkaido University Hospital Department of Emergency Medicine, Iwate Medical University, Fukushima Medical University Hospital, Gunma University Hospital, Tokyo Women&#39
Collaborator
s Medical University Adachi Medical Center, Saiseikai Utsunomiya Hospital, Saiseikai Yokohamashi Tobu Hospital, Kitasato University Hospital, Nagoya Medical Center, Osaka Prefectural Nakakawachi Emergency and Critical Care Center, Nara Prefecture General Medical Center, Wakayama Medical University, Okayama University, Hiroshima University, Kagawa University, Ehime University Hospital, Fukuoka University, University of Occupational and Environmental Health, Saga University, National Hospital Orga
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients 18 years of age or older admitted to the intensive care unit after July 2019 2) Septic shock patients: need a vasopressor to maintain blood pressure >=65 mmHg after infusion, and sustained high lactate >2 mmol/L 3) Noradrenaline (dose >=0.2 gamma) administered within 24 hours after diagnosis of sepsis

Exclusion criteria

Exclusion criteria: 1) Cases of ICU discharge and death within 48 hours of enrollment 2) Patients with a limited long-term prognosis due to coexisting malignancy 3) Cases in which new organ damage had already preceded the onset of sepsis 4) Acute myocardial infarction, heart disease (New York Heart Association[NYHA]4) 5) Severe chronic liver disease (Child-Pugh C) 6) Attending physician's decision 7) Opt-out applicant by patient or proxy consenter

Design outcomes

Primary

MeasureTime frame
28-day mortality

Secondary

MeasureTime frame
ICU mortality 90-day mortality Duration of mechanical ventilation Length of stay in the ICU 90-day reintegration 90-day degree of care(Barthel Index) 90-day short-term memory score(Short Memory Questionnaire) PTSD associated with ICU treatment(Impact of Event Scale-reviced) etc.

Countries

Japan

Contacts

Public ContactYu Kawazoe

Tohoku University Graduate School of Medicine Division of Emergency and Critical Care Medicine

yu.kawazoe.b7@tohoku.ac.jp022-717-7489

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026